183 related articles for article (PubMed ID: 30037008)
1. Cytosolic 5'-Nucleotidase II Silencing in a Human Lung Carcinoma Cell Line Opposes Cancer Phenotype with a Concomitant Increase in p53 Phosphorylation.
Pesi R; Petrotto E; Colombaioni L; Allegrini S; Garcia-Gil M; Camici M; Jordheim LP; Tozzi MG
Int J Mol Sci; 2018 Jul; 19(7):. PubMed ID: 30037008
[TBL] [Abstract][Full Text] [Related]
2. Cytosolic 5'-Nucleotidase II Silencing in Lung Tumor Cells Regulates Metabolism through Activation of the p53/AMPK Signaling Pathway.
Pesi R; Allegrini S; Garcia-Gil M; Piazza L; Moschini R; Jordheim LP; Camici M; Tozzi MG
Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34209768
[TBL] [Abstract][Full Text] [Related]
3. IMP-GMP specific cytosolic 5'-nucleotidase regulates nucleotide pool and prodrug metabolism.
Cividini F; Filoni DN; Pesi R; Allegrini S; Camici M; Tozzi MG
Biochim Biophys Acta; 2015 Jul; 1850(7):1354-61. PubMed ID: 25857773
[TBL] [Abstract][Full Text] [Related]
4. Knockdown of cytosolic 5'-nucleotidase II (cN-II) reveals that its activity is essential for survival in astrocytoma cells.
Careddu MG; Allegrini S; Pesi R; Camici M; Garcia-Gil M; Tozzi MG
Biochim Biophys Acta; 2008 Aug; 1783(8):1529-35. PubMed ID: 18445485
[TBL] [Abstract][Full Text] [Related]
5. Cytosolic 5'-Nucleotidase II Is a Sensor of Energy Charge and Oxidative Stress: A Possible Function as Metabolic Regulator.
Pesi R; Allegrini S; Balestri F; Garcia-Gil M; Cividini F; Colombaioni L; Jordheim LP; Camici M; Tozzi MG
Cells; 2021 Jan; 10(1):. PubMed ID: 33477638
[TBL] [Abstract][Full Text] [Related]
6. Initial studies to define the physiologic role of cN-II.
Filoni DN; Pesi R; Careddu MG; Camici M; Allegrini S; Collavoli A; Scarfone I; Zucchi F; Galli A; Tozzi MG
Nucleosides Nucleotides Nucleic Acids; 2011 Dec; 30(12):1155-60. PubMed ID: 22132970
[TBL] [Abstract][Full Text] [Related]
7. Cell proliferation and drug sensitivity of human glioblastoma cells are altered by the stable modulation of cytosolic 5'-nucleotidase II.
Cividini F; Cros-Perrial E; Pesi R; Machon C; Allegrini S; Camici M; Dumontet C; Jordheim LP; Tozzi MG
Int J Biochem Cell Biol; 2015 Aug; 65():222-9. PubMed ID: 26079827
[TBL] [Abstract][Full Text] [Related]
8. On the physiological role of cytosolic 5'-nucleotidase II (cN-II): pathological and therapeutical implications.
Tozzi MG; Pesi R; Allegrini S
Curr Med Chem; 2013; 20(34):4285-91. PubMed ID: 23992310
[TBL] [Abstract][Full Text] [Related]
9. Stably transfected adherent cancer cell models with decreased expression of 5'-nucleotidase cN-II.
Bricard G; Cros-Perrial E; Machon C; Dumontet C; Jordheim LP
Nucleosides Nucleotides Nucleic Acids; 2016 Dec; 35(10-12):604-612. PubMed ID: 27906612
[TBL] [Abstract][Full Text] [Related]
10. NT5DC2 suppression restrains progression towards metastasis of non-small-cell lung cancer through regulation p53 signaling.
Jin X; Liu X; Zhang Z; Xu L
Biochem Biophys Res Commun; 2020 Dec; 533(3):354-361. PubMed ID: 32962856
[TBL] [Abstract][Full Text] [Related]
11. Cytosolic 5'-nucleotidase II interacts with the leucin rich repeat of NLR family member Ipaf.
Cividini F; Tozzi MG; Galli A; Pesi R; Camici M; Dumontet C; Jordheim LP; Allegrini S
PLoS One; 2015; 10(3):e0121525. PubMed ID: 25811392
[TBL] [Abstract][Full Text] [Related]
12. Determination of the enzymatic activity of cytosolic 5'-nucleotidase cN-II in cancer cells: development of a simple analytical method and related cell line models.
Jordheim LP; Puy JY; Cros-Perrial E; Peyrottes S; Lefebvre I; Périgaud C; Dumontet C
Anal Bioanal Chem; 2015 Jul; 407(19):5747-58. PubMed ID: 25998135
[TBL] [Abstract][Full Text] [Related]
13. Enhanced migration of breast and lung cancer cells deficient for cN-II and CD73 via COX-2/PGE2/AKT axis regulation.
Cadassou O; Raza MZ; Machon C; Gudefin L; Armanet C; Chettab K; Guitton J; Tozzi MG; Dumontet C; Cros-Perrial E; Jordheim LP
Cell Oncol (Dordr); 2021 Feb; 44(1):151-165. PubMed ID: 32970317
[TBL] [Abstract][Full Text] [Related]
14. Enzymatic properties and physiological roles of cytosolic 5'-nucleotidase II.
Itoh R
Curr Med Chem; 2013; 20(34):4260-84. PubMed ID: 23992315
[TBL] [Abstract][Full Text] [Related]
15. Expression of bovine cytosolic 5'-nucleotidase (cN-II) in yeast: nucleotide pools disturbance and its consequences on growth and homologous recombination.
Allegrini S; Filoni DN; Galli A; Collavoli A; Pesi R; Camici M; Tozzi MG
PLoS One; 2013; 8(5):e63914. PubMed ID: 23691116
[TBL] [Abstract][Full Text] [Related]
16. CD73 and cN-II regulate the cellular response to chemotherapeutic and hypoxic stress in lung adenocarcinoma cells.
Raza MZ; Cadassou O; Dumontet C; Cros-Perrial E; Jordheim LP
Biochim Biophys Acta Gen Subj; 2021 May; 1865(5):129842. PubMed ID: 33434633
[TBL] [Abstract][Full Text] [Related]
17. Role of IMP-selective 5'-nucleotidase (cN-II) in hematological malignancies.
Galmarini CM; Jordheim L; Dumontet C
Leuk Lymphoma; 2003 Jul; 44(7):1105-11. PubMed ID: 12916861
[TBL] [Abstract][Full Text] [Related]
18. Distinct roles for recombinant cytosolic 5'-nucleotidase-I and -II in AMP and IMP catabolism in COS-7 and H9c2 rat myoblast cell lines.
Sala-Newby GB; Freeman NV; Skladanowski AC; Newby AC
J Biol Chem; 2000 Apr; 275(16):11666-71. PubMed ID: 10766785
[TBL] [Abstract][Full Text] [Related]
19. Evidence for the involvement of cytosolic 5'-nucleotidase (cN-II) in the synthesis of guanine nucleotides from xanthosine.
Barsotti C; Pesi R; Giannecchini M; Ipata PL
J Biol Chem; 2005 Apr; 280(14):13465-9. PubMed ID: 15699053
[TBL] [Abstract][Full Text] [Related]
20. Identification and characterization of inhibitors of cytoplasmic 5'-nucleotidase cN-II issued from virtual screening.
Jordheim LP; Marton Z; Rhimi M; Cros-Perrial E; Lionne C; Peyrottes S; Dumontet C; Aghajari N; Chaloin L
Biochem Pharmacol; 2013 Feb; 85(4):497-506. PubMed ID: 23220537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
